SGS SA (SGSN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SGS SA (SGSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9867
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and products for compliance with industrial standards and local regulatory requirements, including tax and duty. The company serves various industries, including agriculture and food, chemical, oil and gas, construction, energy, life sciences, arts and culture, mining, public sector, logistics, industrial manufacturing, consumer goods and retail, environment and transportation. It operates through a network of offices and laboratories across Europe, Africa, the Middle East, the Americas and Asia Pacific. SGS is headquartered in Geneva, Switzerland.

SGS SA (SGSN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SGS SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SGS SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SGS SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SGS SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SGS SA, Medical Devices Deals, 2012 to YTD 2018 9
SGS SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SGS SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SGS Partners with Bavarian Nordic 11
Biophytis Enters into Contract with SGS Life Science Services 12
Acquisition 13
SGS (Societe Generale de Surveillance) Acquires Laboratoire de Controle & d’Analyse 13
SGS Acquires Harrison Research Laboratories 14
SGS Acquires Vitrology, Provider Of Biosafety Testing Services 15
SGS SA – Key Competitors 16
SGS SA – Key Employees 17
SGS SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 25
Strategy And Business Planning 25
Aug 28, 2018: SGS to open new biopharmaceutical testing laboratory in Geneva 25
Legal and Regulatory 26
May 11, 2018: Corel Pharma Chem India receives EXCiPACT GMP certification from SGS 26
Oct 23, 2017: ACG Associated Capsules Receives Excipact GMP Certification 27
Sep 06, 2017: Colorcon Awarded EXCiPACT Certification by SGS 28
Product News 29
May 04, 2017: SGS Announces Results of First-in-human Studies Using Novel Virus as Experimental Challenge Agent 29
Other Significant Developments 30
Dec 12, 2017: SGS Introduces GMP DNA Sequencing Service at its Glasgow, UK, Laboratory 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
SGS SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
SGS SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SGS SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SGS SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SGS SA, Deals By Therapy Area, 2012 to YTD 2018 8
SGS SA, Medical Devices Deals, 2012 to YTD 2018 9
SGS SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SGS Partners with Bavarian Nordic 11
Biophytis Enters into Contract with SGS Life Science Services 12
SGS (Societe Generale de Surveillance) Acquires Laboratoire de Controle & d'Analyse 13
SGS Acquires Harrison Research Laboratories 14
SGS Acquires Vitrology, Provider Of Biosafety Testing Services 15
SGS SA, Key Competitors 16
SGS SA, Key Employees 17
SGS SA, Subsidiaries 19

List of Figures
SGS SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SGS SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SGS SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SGS SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SGS SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SGS SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SGS SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SGS SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SGS SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SGS SA (SGSN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nachi-Fujikoshi Corp.:企業の戦略・SWOT・財務分析
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sumitomo Osaka Cement Co Ltd:企業の戦略・SWOT・財務情報
    Sumitomo Osaka Cement Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Osaka Cement Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Program for Appropriate Technology in Health-製薬・医療分野:企業M&A・提携分析
    Summary Program for Appropriate Technology in Health (PATH) is a healthcare organization that offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services. It develo …
  • Singapore Technologies Marine Ltd.:企業の戦略・SWOT・財務情報
    Singapore Technologies Marine Ltd. - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Marine Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Turcas Petrol AS (TRCAS):企業の財務・戦略的SWOT分析
    Summary Turcas Petrol AS (Turcas) is an oil and gas company that distributes and markets lubricants and fuel products. The company operates in the fields of oil and energy, renewable energy, power investments, natural gas projects, fuel retail and lubricants distribution, and power generation and tr …
  • Levi Strauss & Co (LEVI):企業の財務・戦略的SWOT分析
    Levi Strauss & Co (LEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Naturgy Energy Group SA. (NTGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Naturgy Energy Group SA (Naturgy) formerly know as Gas Natural Fenosa, is an integrated gas and electric utility that carries out the exploration, development, liquefaction, regasification, transportation, storage, distribution and commercialization of natural gas. It also undertakes the gen …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Strides Pharma Science Limited (STAR):医療機器:M&Aディール及び事業提携情報
    Summary Strides Pharma Science Limited (Strides Pharma), formerly Strides Shasun Ltd, is a pharmaceutical company which offers generic products. It focuses on the development and manufacture of intellectual property- led niche pharmaceutical products, over-the-counter drugs and nutraceuticals. The c …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aptinyx Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed …
  • Rum Group for Transportation & Tourism Investment:企業の戦略・SWOT・財務情報
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ascend Therapeutics US LLC-製薬・医療分野:企業M&A・提携分析
    Summary Ascend Therapeutics US LLC (Ascend Therapeutics), a subsidiary of Besins Healthcare SA is a healthcare products provider that discovers, develops and markets transdermal drug delivery products. The company’s product comprises estrogel. Its estrogel is a non patch transdermal estrogen therapy …
  • Neftisa:石油・ガス:M&Aディール及び事業提携情報
    Summary Neftisa is an upstream oil and gas company. The company's activities include prospecting and development of hydrocarbon reservoirs, oil production, gas condensate recovery, conversion of oil associated gas, oil-and-gas fields development and extraction, maintenance and monitoring of oil serv …
  • Axxam SpA-製薬・医療分野:企業M&A・提携分析
    Summary Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among …
  • Sinocare Meditech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sinocare Meditech Inc (Sinocare Meditech) formerly known as Freedom Meditech Inc, is a medical device company that provides ophthalmic medical devices. The company develops and commercializes ophthalmic medical devices for both chronic disease detection and the management of diabetes. It pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆